WS13.1 – Direct to Patient for Europe
- Date:
- 14 October 2026
- Time:
- -
This advanced level session explores actionable strategies to enhance the feasibility of Direct-to-Patient (DTP) distribution in clinical trials in Europe. Drawing on Tufts & GCSG Impact Summary insights, we’ll examine key challenges—technical support gaps, delivery logistics, and scheduling inefficiencies—and discuss solutions to improve site and patient experiences. Attendees will leave with a roadmap for maintaining DTP as a viable and patient-centric trial model.